Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B
- 6 November 2001
- journal article
- Published by Elsevier in Acta Tropica
- Vol. 81 (2) , 151-157
- https://doi.org/10.1016/s0001-706x(01)00197-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral AgentClinical Infectious Diseases, 2001
- Ether–lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether–lipid analogues in LeishmaniaMolecular and Biochemical Parasitology, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Miltefosine — The Long-Awaited Therapy for Visceral Leishmaniasis?New England Journal of Medicine, 1999
- The sensitivity of Leishmania species to aminosidineJournal of Antimicrobial Chemotherapy, 1995
- Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in GuatemalaThe Journal of Infectious Diseases, 1992
- Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicityInternational Journal of Cancer, 1990
- Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotesMolecular and Biochemical Parasitology, 1988
- Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotesMolecular and Biochemical Parasitology, 1987
- An in Vitro Model for Investigation of Chemotherapeutic Agents in LeishmaniasisThe Journal of Infectious Diseases, 1980